Axa’s Xperi XPER Stock Holding History

Axa’s Portfolio XPER Stock Details XPER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-86,961	Closed	-$950K	–	1180
2023 Q1	$950K	Buy	86,961 +3,629	+4%	+$37.8K	﹤0.01%	875
2022 Q4	$717K	Buy	+83,332	New	+$953K	﹤0.01%	938

Other funds holding XPER

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Axa's XPER Position: Q2 2023 in Review

Axa sold out of Xperi (XPER) in Q2 2023, closing a stake of 86,961 shares — an estimated $950K sold.

Axa first reported a position in XPER in Q4 2022 and held it in 2 quarters. The position peaked at $950K in Q1 2023. 160 funds tracked by Wall St. Rank hold XPER as of Q2 2023.

Axa reported no remaining Xperi position as of Q2 2023 after selling out during the quarter.
Axa sold 86,961 Xperi shares in Q2 2023, an estimated $950K.
Axa first reported a position in Xperi in Q4 2022 and held it in 2 quarters.
Axa's Xperi position peaked at $950K in Q1 2023.
160 funds tracked by Wall St. Rank held Xperi as of Q2 2023.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.